Liver transplantation in alcoholic liver disease current status and controversies

World Journal of Gastroenterology

Volumn 19, Issue 36, 2013, Pages 5953-5963

  Singal, Ashwani K ^a   Chaha, Khushdeep S ^b   Rasheed, Khalid ^b   Anand, Bhupinderjit S ^c  

^a University of Alabama at Birmingham   (United States)

^b Department of Medicine ^*  (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Alcoholic hepatitis; Alcoholic liver disease; Liver transplantation; Recidivism; Six months rule; Transplant evaluation

Indexed keywords

ACETALDEHYDE; BACLOFEN; CARBOHYDRATE DEFICIENT TRANSFERRIN; CORTICOSTEROID; CYTOCHROME P450; ETHYL GLUCURONIDE; GAMMA GLUTAMYLTRANSFERASE; NICOTINE; PENTOXIFYLLINE; PLACEBO;

ALCOHOL ABSTINENCE; ALCOHOL ABUSE; ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ALCOHOL REHABILITATION PROGRAM; AMNESIA; CARDIOVASCULAR DISEASE; CHRONIC PANCREATITIS; DRINKING BEHAVIOR; END STAGE LIVER DISEASE; GRAFT FAILURE; HOSPITAL READMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; METABOLIC SYNDROME X; NUTRITIONAL STATUS; PERIPHERAL NEUROPATHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECIDIVISM; REVIEW; SOCIAL PSYCHOLOGY; SYSTEMATIC REVIEW (TOPIC); WERNICKE ENCEPHALOPATHY;

ALCOHOLIC HEPATITIS; ALCOHOLIC LIVER DISEASE; LIVER TRANSPLANTATION; RECIDIVISM; SIX MONTHS RULE; TRANSPLANT EVALUATION;

ADRENAL CORTEX HORMONES; ALCOHOL ABSTINENCE; ALCOHOLISM; HUMANS; LIVER DISEASES, ALCOHOLIC; LIVER TRANSPLANTATION; PATIENT SELECTION; RECURRENCE; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; WAITING LISTS;

EID: 84885587550     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i36.5953     Document Type: Review

References (95)

1. Mandayam S, Jamal MM, Morgan TR. Epidemiology of alcoholic liver disease. Semin Liver Dis 2004; 24: 217-232 [PMID: 15349801 DOI: 10.1055/s-2004-832936]
2. Becker U, Deis A, Sørensen TI, Grønbaek M, Borch-Johnsen K, Müller CF, Schnohr P, Jensen G. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 1996; 23: 1025-1029 [PMID: 8621128 DOI: 10.1002/hep.510230513]
3. Singal AK, Anand BS. Mechanisms of synergy between alcohol and hepatitis C virus. J Clin Gastroenterol 2007; 41: 761-772 [PMID: 17700425 DOI: 10.1097/MCG.0b013e3180381584]
4. Raynard B, Balian A, Fallik D, Capron F, Bedossa P, Chaput JC, Naveau S. Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 2002; 35: 635-638 [PMID: 11870378 DOI: 10.1053/jhep.2002.31782]
5. World Health Organization. Global Status Report on Alcohol and Health 2011. Available from: URL: http://www.who. int/substance_abuse/publications/global_alcohol_report/ en/
6. Bouchery EE, Harwood HJ, Sacks JJ, Simon CJ, Brewer RD. Economic costs of excessive alcohol consumption in the U.S., 2006. Am J Prev Med 2011; 41: 516-524 [PMID: 22011424 DOI: 10.1016/j.amepre.2011.06.045]
7. Bachir NM, Larson AM. Adult liver transplantation in the United States. Am J Med Sci 2012; 343: 462-469 [PMID: 22683615 DOI: 10.1097/MAJ.0b013e3182308b66]
8. Singal AK, Guturu P, Hmoud B, Kuo YF, Salameh H, Wiesner RH. Evolving frequency and outcomes of liver transplantation based on etiology of liver disease. Transplantation 2013; 95: 755-760 [PMID: 23370710 DOI: 10.1097/ TP.0b013e31827afb3a]
9. Hurtova M, Bachir D, Lee K, Calderaro J, Decaens T, Kluger MD, Zafrani ES, Cherqui D, Mallat A, Galactéros F, Duvoux C. Transplantation for liver failure in patients with sickle cell disease: challenging but feasible. Liver Transpl 2011; 17: 381-392 [PMID: 21445921 DOI: 10.1002/lt.22257]
10. Starzl TE, Van Thiel D, Tzakis AG, Iwatsuki S, Todo S, Marsh JW, Koneru B, Staschak S, Stieber A, Gordon RD. Orthotopic liver transplantation for alcoholic cirrhosis. JAMA 1988; 260: 2542-2544 [PMID: 3050180 DOI: 10.1001/ jama.260.17.2542]
11. Burra P, Senzolo M, Adam R, Delvart V, Karam V, Germani G, Neuberger J. Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry). Am J Transplant 2010; 10: 138-148 [PMID: 19951276 DOI: 10.1111/j.1600-6143.2009.02869]
12. Julapalli VR, Kramer JR, El-Serag HB. Evaluation for liver transplantation: adherence to AASLD referral guidelines in a large Veterans Affairs center. Liver Transpl 2005; 11: 1370-1378 [PMID: 16184521 DOI: 10.1002/lt.20434]
13. Day E, Best D, Sweeting R, Russell R, Webb K, Georgiou G, Neuberger J. Detecting lifetime alcohol problems in individuals referred for liver transplantation for nonalcoholic liver failure. Liver Transpl 2008; 14: 1609-1613 [PMID: 18975295 DOI: 10.1002/lt.21528]
14. Bajaj JS, Saeian K, Hafeezullah M, Franco J, Thompson A, Anderson R. Failure to fully disclose during pretransplant psychological evaluation in alcoholic liver disease: a driving under the influence corroboration study. Liver Transpl 2008; 14: 1632-1636 [PMID: 18975271 DOI: 10.1002/lt.21574]
15. Lucey MR, Brown KA, Everson GT, Fung JJ, Gish R, Keeffe EB, Kneteman NM, Lake JR, Martin P, McDiarmid SV, Rakela J, Shiffman ML, So SK, Wiesner RH. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 1997; 3: 628-637 [PMID: 9404965]
16. Veldt BJ, Lainé F, Guillygomarc'h A, Lauvin L, Boudjema K, Messner M, Brissot P, Deugnier Y, Moirand R. Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing. J Hepatol 2002; 36: 93-98 [PMID: 11804670 DOI: 10.1016/S0168-8278(01)00228-8]
17. O'Shea RS, Dasarathy S, McCullough AJ. Alcoholic liver disease. Hepatology 2010; 51: 307-328 [PMID: 20034030 DOI: 20034030]
18. Leong J, Im GY. Evaluation and selection of the patient with alcoholic liver disease for liver transplant. Clin Liver Dis 2012; 16: 851-863 [PMID: 23101986 DOI: 23101986]
19. Singal AK, Kamath PS, Francisco Ziller N, Dicecco S, Shoreibah M, Kremers W, Charlton MR, Heimbach JK, Watt KD, Shah VH. Nutritional status of patients with alcoholic cirrhosis undergoing liver transplantation: time trends and impact on survival. Transpl Int 2013; 26: 788-794 [PMID: 23751180 DOI: 10.1111/tri.12123]
20. Olbrisch ME, Levenson JL. Liver transplantation for alcoholic cirrhosis. JAMA 1989; 261: 2958 [PMID: 2654426 DOI: 10.1001/jama.261.20.2958b]
21. Weinrieb RM, Van Horn DH, Lynch KG, Lucey MR. A randomized, controlled study of treatment for alcohol dependence in patients awaiting liver transplantation. Liver Transpl 2011; 17: 539-547 [PMID: 21506242 DOI: 10.1002/lt.22259]
22. Heydtmann M. The GABA-B agonist Baclofen improves alcohol consumption, psychometrics and may have effect on hospital admission rates in patients with alcoholic liver disease. Hepatology 2012; 56: A1932
23. Addolorato G, Leggio L, Ferrulli A, Cardone S, Vonghia L, Mirijello A, Abenavoli L, D'Angelo C, Caputo F, Zambon A, Haber PS, Gasbarrini G. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet 2007; 370: 1915-1922 [PMID: 18068515 DOI: 10.1016/S0140-6736(07)61814-5]
24. Carbonneau M, Jensen LA, Bain VG, Kelly K, Meeberg G, Tandon P. Alcohol use while on the liver transplant waiting list: a single-center experience. Liver Transpl 2010; 16: 91-97 [PMID: 19866447 DOI: 10.1002/lt.21957]
25. Hempel JM, Greif-Higer G, Kaufmann T, Beutel ME. Detection of alcohol consumption in patients with alcoholic liver cirrhosis during the evaluation process for liver transplantation. Liver Transpl 2012; 18: 1310-1315 [PMID: 22577089 DOI: 10.1002/lt.23468]
26. Anton RF, Lieber C, Tabakoff B. Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study. Alcohol Clin Exp Res 2002; 26: 1215-1222 [PMID: 12198396 DOI: 10.1111/j.1530-0277.2002.tb02658.x]
27. Fleming MF, Anton RF, Spies CD. A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels. Alcohol Clin Exp Res 2004; 28: 1347-1355 [PMID: 15365305 DOI: 10.1097/01. ALC.0000139815.89794.BE]
28. Staufer K, Andresen H, Vettorazzi E, Tobias N, Nashan B, Sterneck M. Urinary ethyl glucuronide as a novel screening tool in patients pre-and post-liver transplantation improves detection of alcohol consumption. Hepatology 2011; 54: 1640-1649 [PMID: 21809364 DOI: 10.1002/hep.24596]
29. Helander A, Dahl H. Urinary tract infection: a risk factor for false-negative urinary ethyl glucuronide but not ethyl sulfate in the detection of recent alcohol consumption. Clin Chem 2005; 51: 1728-1730 [PMID: 16120954 DOI: 10.1373/ clinchem.2005.051565]
30. Wurst FM, Dresen S, Allen JP, Wiesbeck G, Graf M, Weinmann W. Ethyl sulphate: a direct ethanol metabolite reflecting recent alcohol consumption. Addiction 2006; 101: 204-211 [PMID: 16445549 DOI: 10.1111/j.1360-0443.2005.01245.x]
31. Sterneck M, Yegles M, von Rothkirch G, Staufer K, Vettorazzi E, Schulz KH, Tobias N, Graeser C, Fischer L, Nashan B, Andresen-Streichert H. Determination of ethyl glucuronide in hair improves evaluation of long-term alcohol abstention in liver transplant candidates. Liver Int 2013; Epub ahead of print [PMID: 23829409 DOI: 10.1111/liv.12243]
32. Society of hair testing. Consensus of the society of hair testing for chronic excessive alcohol consumption. Available from: URL: http://soht.org/pdf/consensus_EtG_2009
33. Litten RZ, Bradley AM, Moss HB. Alcohol biomarkers in applied settings: recent advances and future research opportunities. Alcohol Clin Exp Res 2010; 34: 955-967 [PMID: 20374219 DOI: 10.1111/j.1530-0277.2010.01170.x]
34. Newton SE. Recidivism and return to work posttransplant. Recipients with substance abuse histories. J Subst Abuse Treat 1999; 17: 103-108 [PMID: 10435257 DOI: 10.1016/ S0740-5472(98)00059-2]
35. Lucey MR, Carr K, Beresford TP, Fisher LR, Shieck V, Brown KA, Campbell DA, Appelman HD. Alcohol use after liver transplantation in alcoholics: a clinical cohort follow-up study. Hepatology 1997; 25: 1223-1227 [PMID: 9141441 DOI: 10.1002/hep.510250526]
36. Tandon P, Goodman KJ, Ma MM, Wong WW, Mason AL, Meeberg G, Bergsten D, Carbonneau M, Bain VG. A shorter duration of pre-transplant abstinence predicts problem drinking after liver transplantation. Am J Gastroenterol 2009; 104: 1700-1706 [PMID: 19471253 DOI: 10.1038/ajg.2009.226]
37. Burra P, Mioni D, Cillo U, Fagiuoli S, Senzolo M, Naccarato R, Martines D. Long-term medical and psycho-social evaluation of patients undergoing orthotopic liver transplantation for alcoholic liver disease. Transpl Int 2000; 13 Suppl 1: S174-S178 [PMID: 11111991]
38. Dew MA, DiMartini AF, Steel J, De Vito Dabbs A, Myaskovsky L, Unruh M, Greenhouse J. Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs. Liver Transpl 2008; 14: 159-172 [PMID: 18236389 DOI: 10.1002/lt.21278]
39. DiMartini A, Dew MA, Day N, Fitzgerald MG, Jones BL, deVera ME, Fontes P. Trajectories of alcohol consumption following liver transplantation. Am J Transplant 2010; 10: 2305-2312 [PMID: 20726963 DOI: 10.1111/ j.1600-6143.2010.03232]
40. McCallum S, Masterton G. Liver transplantation for alcoholic liver disease: a systematic review of psychosocial selection criteria. Alcohol Alcohol 2006; 41: 358-363 [PMID: 16636009 DOI: 10.1093/alcalc/agl033]
41. Yates WR, Martin M, LaBrecque D, Hillebrand D, Voigt M, Pfab D. A model to examine the validity of the 6-month abstinence criterion for liver transplantation. Alcohol Clin Exp Res 1998; 22: 513-517 [PMID: 9581661]
42. United Network for Organ Sharing. Available from: URL: http://www.unos.org
43. De Bona M, Ponton P, Ermani M, Iemmolo RM, Feltrin A, Boccagni P, Gerunda G, Naccarato R, Rupolo G, Burra P. The impact of liver disease and medical complications on quality of life and psychological distress before and after liver transplantation. J Hepatol 2000; 33: 609-615 [PMID: 11059865 DOI: 11059865]
44. Pereira SP, Howard LM, Muiesan P, Rela M, Heaton N, Williams R. Quality of life after liver transplantation for alcoholic liver disease. Liver Transpl 2000; 6: 762-768 [PMID: 11084065]
45. Cowling T, Jennings LW, Goldstein RM, Sanchez EQ, Chinnakotla S, Klintmalm GB, Levy MF. Societal reintegration after liver transplantation: findings in alcohol-related and nonalcohol-related transplant recipients. Ann Surg 2004; 239: 93-98 [PMID: 14685106]
46. Lucey MR, Schaubel DE, Guidinger MK, Tome S, Merion RM. Effect of alcoholic liver disease and hepatitis C infection on waiting list and posttransplant mortality and transplant survival benefit. Hepatology 2009; 50: 400-406 [PMID: 19472315]
47. Singal AK, Hmoud BS, Guturu P, Kuo YF. Outcome after liver transplantation for cirrhosis due to alcohol and hepatitis C: comparison to alcoholic cirrhosis and hepatitis C cirrhosis. J Clin Gastroenterol 2013; 47: 727-733 [PMID: 23751845]
48. Aguilera V, Berenguer M, Rubín A, San-Juan F, Rayón JM, Prieto M, Mir J. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis. Liver Transpl 2009; 15: 79-87 [PMID: 19109849 DOI: 10.1002/lt.21626]
49. Jain A, DiMartini A, Kashyap R, Youk A, Rohal S, Fung J. Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus. Transplantation 2000; 70: 1335-1342 [PMID: 11087149]
50. Faure S, Herrero A, Jung B, Duny Y, Daures JP, Mura T, Assenat E, Bismuth M, Bouyabrine H, Donnadieu-Rigole H, Navarro F, Jaber S, Larrey D, Pageaux GP. Excessive alcohol consumption after liver transplantation impacts on long-term survival, whatever the primary indication. J Hepatol 2012; 57: 306-312 [PMID: 22521352 DOI: 10.1016/j.jhep.2012.03.014]
51. Schmeding M, Heidenhain C, Neuhaus R, Neuhaus P, Neumann UP. Liver transplantation for alcohol-related cirrhosis: a single centre long-term clinical and histological follow-up. Dig Dis Sci 2011; 56: 236-243 [PMID: 20499174 DOI: 10.1007/ s10620-010-1281-7]
52. Cuadrado A, Fábrega E, Casafont F, Pons-Romero F. Alcohol recidivism impairs long-term patient survival after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl 2005; 11: 420-426 [PMID: 15776421]
53. Rowe IA, Webb K, Gunson BK, Mehta N, Haque S, Neuberger J. The impact of disease recurrence on graft survival following liver transplantation: a single centre experience. Transpl Int 2008; 21: 459-465 [PMID: 18225996 DOI: 10.1111/ j.1432-2277.2007.00628]
54. Yusoff IF, House AK, De Boer WB, Ferguson J, Garas G, Heath D, Mitchell A, Jeffrey Gp. Disease recurrence after liver transplantation in Western Australia. J Gastroenterol Hepatol 2002; 17: 203-207 [PMID: 11966952]
55. Conjeevaram HS, Hart J, Lissoos TW, Schiano TD, Dasgupta K, Befeler AS, Millis JM, Baker AL. Rapidly progressive liver injury and fatal alcoholic hepatitis occurring after liver transplantation in alcoholic patients. Transplantation 1999; 67: 1562-1568 [PMID: 10401763 DOI: 10.1097/00007890-19990627 0-00010]
56. DiMartini A, Dew MA, Chaiffetz D, Fitzgerald MG, Devera ME, Fontes P. Early trajectories of depressive symptoms after liver transplantation for alcoholic liver disease predicts longterm survival. Am J Transplant 2011; 11: 1287-1295 [PMID: 21645258 DOI: 10.1111/j.1600-6143.2011]
57. Cannesson AB, Louvet A. Prevalence and natural history of recurrent alcoholic cirrhosis after liver transplantation. Hepatology 2012; 56: A652
58. Watt KD, Charlton MR. Metabolic syndrome and liver transplantation: a review and guide to management. J Hepatol 2010; 53: 199-206 [PMID: 20451282]
59. Singal AKWK, Heimbach JH, Charlton MR. Recurrence of Metabolic syndrome and non-alcoholic steatohepatitis after liver transplantation. Hepatology 2012; 56 Suppl: A499
60. Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Charlton MR. Evolution of causes and risk factors for mortality post-liver= transplant: results of the NIDDK long-term follow-up study. Am J Transplant 2010; 10: 1420-1427 [PMID: 20486907 DOI: 10.1111/j.1600-6143.2010.03126.x]
61. Penn I, Starzl TE. Malignant tumors arising de novo in immunosuppressed organ transplant recipients. Transplantation 1972; 14: 407-417 [PMID: 4345337]
62. Chandok N, Watt KD. Burden of de novo malignancy in the liver transplant recipient. Liver Transpl 2012; 18: 1277-1289 [PMID: 22887956 DOI: 10.1002/lt.23531]
63. Chak E, Saab S. Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review. Liver Int 2010; 30: 1247-1258 [PMID: 20602682 DOI: 10.1111/ j.1478-3231.2010.02303.x]
64. Tjon AS, Sint Nicolaas J, Kwekkeboom J, de Man RA, Kazemier G, Tilanus HW, Hansen BE, van der Laan LJ, Tha-In T, Metselaar HJ. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age. Liver Transpl 2010; 16: 837-846 [PMID: 20583092 DOI: 10.1002/lt.22064]
65. Collett D, Mumford L, Banner NR, Neuberger J, Watson C. Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit. Am J Transplant 2010; 10: 1889-1896 [PMID: 20659094 DOI: 10.1111/ j.1600-6143.2010.03181]
66. Sampaio MS, Cho YW, Qazi Y, Bunnapradist S, Hutchinson IV, Shah T. Posttransplant malignancies in solid organ adult recipients: an analysis of the U.S. National Transplant Database. Transplantation 2012; 94: 990-998 [PMID: 23085553 DOI: 10.1097/TP.0b013e318270bc7b]
67. Jiménez-Romero C, Manrique Municio A, Marqués Medina E, Colina F, Ortega Domene P, Gómez Sanz R, Meneu Diaz JC, Abradelo de Usera M, Moreno Elola A, Moreno Gonzalez E. Incidence of de novo nonmelanoma skin tumors after liver transplantation for alcoholic and nonalcoholic liver diseases. Transplant Proc 2006; 38: 2505-2507 [PMID: 17097982 DOI: 10.1016/j.transproceed.2006.08.065]
68. Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Sanchez W, Gores GJ. Long-term probability of and mortality from de novo malignancy after liver transplantation. Gastroenterology 2009; 137: 2010-2017 [PMID: 19766646]
69. Oo YH, Gunson BK, Lancashire RJ, Cheng KK, Neuberger JM. Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales. Transplantation 2005; 80: 759-764 [PMID: 16210962]
70. Jiménez C, Marqués E, Loinaz C, Romano DR, Gómez R, Meneu JC, Hernández-Vallejo G, Alonso O, Abradelo M, Garcia I, Moreno E. Upper aerodigestive tract and lung tumors after liver transplantation. Transplant Proc 2003; 35: 1900-1901 [PMID: 12962840 DOI: 10.1016/S0041-1345(03)00641-9]
71. Dedhia RC, Grandis JR, Fontes PA, Johnson JT, Weissfeld J. Screening for head and neck cancer in liver transplant candidates: a review of 11 years of experience at the University of Pittsburgh. Laryngoscope 2012; 122: 539-542 [PMID: 22183711 DOI: 10.1002/lary.22406]
72. Aberg F, Pukkala E, Höckerstedt K, Sankila R, Isoniemi H. Risk of malignant neoplasms after liver transplantation: a population-based study. Liver Transpl 2008; 14: 1428-1436 [PMID: 18825704 DOI: 10.1002/lt.21475]
73. Herrero JI, Lorenzo M, Quiroga J, Sangro B, Pardo F, Rotellar F, Alvarez-Cienfuegos J, Prieto J. De Novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival. Liver Transpl 2005; 11: 89-97 [PMID: 15690541 DOI: 10.1002/lt.20319]
74. Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 2007; 7: 599-612 [PMID: 17646865]
75. Ehlers SL, Rodrigue JR, Widows MR, Reed AI, Nelson DR. Tobacco use before and after liver transplantation: a single center survey and implications for clinical practice and research. Liver Transpl 2004; 10: 412-417 [PMID: 15004770 DOI: 10.1002/lt.20087]
76. Jiménez C, Rodríguez D, Marqués E, Loinaz C, Alonso O, Hernández-Vallejo G, Marín L, Rodríguez F, García I, Moreno E. De novo tumors after orthotopic liver transplantation. Transplant Proc 2002; 34: 297-298 [PMID: 11959293 DOI: 10.1016/S0041-1345(01)02770-1]
77. Gelson W, Hoare M, Dawwas MF, Vowler S, Gibbs P, Alexander G. The pattern of late mortality in liver transplant recipients in the United Kingdom. Transplantation 2011; 91: 1240-1244 [PMID: 21516069]
78. Dumortier J, Guillaud O, Adham M, Boucaud C, Delafosse B, Bouffard Y, Paliard P, Scoazec JY, Boillot O. Negative impact of de novo malignancies rather than alcohol relapse on survival after liver transplantation for alcoholic cirrhosis: a retrospective analysis of 305 patients in a single center. Am J Gastroenterol 2007; 102: 1032-1041 [PMID: 17313502 DOI: 10.1111/j.1572-0241.2007.01079.x]
79. Finkenstedt A, Graziadei IW, Oberaigner W, Hilbe W, Nachbaur K, Mark W, Margreiter R, Vogel W. Extensive surveillance promotes early diagnosis and improved survival of de novo malignancies in liver transplant recipients. Am J Transplant 2009; 9: 2355-2361 [PMID: 19663894 DOI: 10.1111/ j.1600-6143.2009.02766]
80. Herrero JI, Alegre F, Quiroga J, Pardo F, Iñarrairaegui M, Sangro B, Rotellar F, Montiel C, Prieto J. Usefulness of a program of neoplasia surveillance in liver transplantation. A preliminary report. Clin Transplant 2009; 23: 532-536 [PMID: 19681977]
81. Lewis MB, Howdle PD. Neurologic complications of liver transplantation in adults. Neurology 2003; 61: 1174-1178 [PMID: 14610116]
82. Showstack J, Katz PP, Lake JR, Brown RS, Dudley RA, Belle S, Wiesner RH, Zetterman RK, Everhart J. Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantation Database Group. JAMA 1999; 281: 1381-1386 [PMID: 10217053 DOI: 10.1001/jama.281.15.1381]
83. Buis CI, Wiesner RH, Krom RA, Kremers WK, Wijdicks EF. Acute confusional state following liver transplantation for alcoholic liver disease. Neurology 2002; 59: 601-605 [PMID: 12196657]
84. Keeffe EB. Comorbidities of alcoholic liver disease that affect outcome of orthotopic liver transplantation. Liver Transpl Surg 1997; 3: 251-257 [PMID: 9346748 DOI: 10.1002/ lt.500030310]
85. Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med 2009; 360: 2758-2769 [PMID: 19553649 DOI: 10.1056/NEJMra0805786]
86. Singal AK, Kuo YF, Anand BS. Hepatitis C virus infection in alcoholic hepatitis: prevalence patterns and impact on in-hospital mortality. Eur J Gastroenterol Hepatol 2012; 24: 1178-1184 [PMID: 22735607]
87. Tomé S, Martinez-Rey C, González-Quintela A, Gude F, Brage A, Otero E, Abdulkader I, Forteza J, Bustamante M, Varo E. Influence of superimposed alcoholic hepatitis on the outcome of liver transplantation for end-stage alcoholic liver disease. J Hepatol 2002; 36: 793-798 [PMID: 12044530 DOI: 10.1016/S0168-8278(02)00047-8]
88. Paula H, Asrani SK, Boetticher NC, Pedersen R, Shah VH, Kim WR. Alcoholic liver disease-related mortality in the United States: 1980-2003. Am J Gastroenterol 2010; 105: 1782-1787 [PMID: 20179691]
89. Singal AK, Shah VH. Alcoholic hepatitis: prognostic models and treatment. Gastroenterol Clin North Am 2011; 40: 611-639 [PMID: 21893277]
90. Singal AK, Sagi S, Kuo YF, Weinman S. Impact of hepatitis C virus infection on the course and outcome of patients with acute alcoholic hepatitis. Eur J Gastroenterol Hepatol 2011; 23: 204-209 [PMID: 21258239]
91. Singal AK, Duchini A. Liver transplantation in acute alcoholic hepatitis: Current status and future development. World J Hepatol 2011; 3: 215-218 [PMID: 21954410 DOI: 10.4254/wjh.v3.i8.215]
92. Mathurin P, Moreno C, Samuel D, Dumortier J, Salleron J, Durand F, Castel H, Duhamel A, Pageaux GP, Leroy V, Dharancy S, Louvet A, Boleslawski E, Lucidi V, Gustot T, Francoz C, Letoublon C, Castaing D, Belghiti J, Donckier V, Pruvot FR, Duclos-Vallée JC. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med 2011; 365: 1790-1800 [PMID: 22070476]
93. Singal AK, Bashar H, Anand BS, Jampana SC, Singal V, Kuo YF. Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: exploratory analysis from the UNOS database. Hepatology 2012; 55: 1398-1405 [PMID: 22213344]
94. Pageaux GP, Bismuth M, Perney P, Costes V, Jaber S, Possoz P, Fabre JM, Navarro F, Blanc P, Domergue J, Eledjam JJ, Larrey D. Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter? J Hepatol 2003; 38: 629-634 [PMID: 12713874 DOI: 10.1016/S0168-8278(03)00088-6]
95. Pfitzmann R, Schwenzer J, Rayes N, Seehofer D, Neuhaus R, Nüssler NC. Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl 2007; 13: 197-205 [PMID: 17205563]